Detection of donor-specific anti-HLA antibodies with flow cytometry in eluates and sera from renal transplant recipients with chronic allograft nephropathy

Transplantation

Volumn 76, Issue 2, 2003, Pages 395-400

  Martin, Laurent ^a,d   Guignier, Fredy ^a,b   Mousson, Christiane ^a,c   Rageot, David ^a   Justrabo, Eve ^a   Rifle, Gérard ^a,c  

^a School of Medicine   (France)

^b ETABLISSEMENT FRANÇAIS DU SANG   (France)

^c DIJON UNIVERSITY HOSPITAL   (France)

^d UNIVERSITÉ DE BOURGOGNE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DONOR SPECIFIC ANTIBODY; HLA ANTIBODY; HLA CLASS 1 ANTIBODY; HLA CLASS 2 ANTIBODY; IMMUNOGLOBULIN G; UNCLASSIFIED DRUG;

ADULT; ANTIBODY DETECTION; ARTICLE; CHRONIC ALLOGRAFT NEPHROPATHY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ELUTION; FEMALE; FLOW CYTOMETRY; GLOMERULOPATHY; GRAFT REJECTION; HLA TYPING; HUMAN; HUMAN TISSUE; KIDNEY ALLOGRAFT REJECTION; KIDNEY BIOPSY; KIDNEY TRANSPLANTATION; MALE; PATHOGENESIS; PRIORITY JOURNAL; THROMBOSIS;

AUTOANTIBODIES; CHRONIC DISEASE; FEMALE; FLOW CYTOMETRY; GRAFT REJECTION; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; LYMPHOCYTES; MALE; MIDDLE AGED; TISSUE DONORS;

EID: 0043269204     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000078895.24606.45     Document Type: Article

References (23)

1. Racusen LC, Solez K, Colvin RB, et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999; 55: 713.
2. Paul LC. Immunologic risk factors for chronic renal allograft dysfunction. Transplantation 2001; 71: SS1.
3. Fellström B. Nonimmune risk factors for chronic renal allograft dysfunction. Transplantation 2001; 71: SS10.
4. Russell PS, Chase CM, Winn HJ, et al. Coronary atherosclerosis in transplanted mouse hearts. II. Importance of humoral immunity. J Immunol 1994; 152: 5135.
5. Scornik JC, Salomon DR, Lim PB, et al. Posttransplant antidonor antibodies and graft rejection: evaluation by two-color flow cytometry. Transplantation 1989; 47: 287.
6. Saiki RK, Walsh PS, Levenson CH, et al. Genetic analysis of amplified DNA with immobilized sequence-specific oligonucleotide probes. Proc Natl Acad Sci USA 1989; 86: 6230.
7. Pei R, Wang G, Tarsitani C, et al. Simultaneous HLA class I and class II antibodies screening with flow cytometry. Hum Immunol 1998; 59: 313.
8. Bray RA. Flow cytometry crossmatching for solid organ transplantation. Methods Cell Biol 1994; 41: 103.
9. Brando B, Sommaruga E. Flow cytometry cross-match. Eur J Histochem 1996; 40(S1): 53.
10. Martin S, Dyer PA, Mallick NP, et al. Posttransplant anti-donor lymphocytotoxic antibody production in relation to graft outcome. Transplantation 1987; 44: 50.
11. Christiaans MHL, Nieman F, van Hoff JP, et al. Detection of HLA class I and II antibodies by ELISA and complement-dependent cytotoxicity before and after transplantation. Transplantation 2000; 69: 917.
12. Piazza A, Poggi E, Borrelli L, et al. Impact of donor-specific antibodies on chronic rejection occurrence and graft loss in renal transplantation: posttransplantation analysis using flow cytometric techniques. Transplantation 2001; 71: 1106.
13. Abe M, Kawai T, Futatsuyama K, et al. Postoperative production of anti-donor antibody and chronic rejection in renal transplantation. Transplantation 1997; 63: 1616.
14. McKenna RM, Takemoto S, Terasaki PI. Anti-HLA antibodies after solid organ transplantation. Transplantation 2000; 69: 319.
15. McMahon MJ, O'Kennedy R. Polyreactivity as an acquired artefact, rather than physiologic property of antibodies: evidence that monoreactive antibodies may gain the ability to bind to multiple antigens after exposure to low pH. J Immunol Methods 2000; 241: 1.
16. Mauiyyedi S, Della Pelle P, Saidman S, et al. Chronic humoral rejection: identification of antibody-mediated chronic renal allograft rejection by C4d deposits in peritubular capillaries. J Am Soc Nephrol 2001; 12: 574.
17. Ferry BL, Welsh KI, Dunn MJ, et al. Anti-cell surface endothelial antibodies in sera from cardiac and kidney transplant recipients: association with chronic rejection. Transplant Immunol 1997; 5: 17.
18. Ball B, Mousson C, Ratignier C, et al. Antibodies to vascular endothelial cells in chronic rejection of renal allografts. Transplant Proc 2000; 32: 353.
19. Halloran PF, Schaut J, Solez K, et al. Significance of anti-class I antibody response. I. Clinical and pathologic features of anti-class I-mediated rejection. Transplantation 1990; 49: 85.
20. Russell PS, Chase CM, Colvin RB. Alloantibody and T-cell mediated immunity in the pathogenesis of transplant arteriosclerosis: lack of progression to sclerotic lesions in B cell-deficient mice. Transplantation 1997; 64: 1531.
21. Cramer DV, Shirwan H. The importance of humoral immune response in chronic rejection. Transpl Rev 1998; 12: 166.
22. Shirwan H. Chronic allograft rejection. Do the TH2 cells preferentially induced by indirect allorecognition play a dominant role? Transplantation 1999; 68: 715.
23. Theruvath TP, Saidman SL, Mauiyyedi S, et al. Control of antidonor antibody production with tacrolimus and mycophenolate mofetil in renal allograft recipients with chronic rejection. Transplantation 2001; 72: 77.